Moderna Price Target Raised To $139 From $107 At Goldman Sachs By: TalkMarkets November 25, 2020 at 07:19 AM EST Goldman Sachs analyst Salveen Richter raised the firm's price target on Moderna to $139 from $107 and keeps a Buy rating on the shares. Read More >> Related Stocks: Moderna Inc